CD20‐negative diffuse large B‐cell lymphoma presenting with lactic acidosis

E-ISSN： 1096-8652|90|3|E49-E50

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.3, 2015-03, pp. : E49-E50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinicopathologic Characteristics of CD99-Positive Diffuse Large B-Cell Lymphoma

Acta Haematologica, Vol. 125, Iss. 3, 2010-12 ,pp. : 167-174

Karger

Access to resources Recommend Favorite

Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group

Case Reports in Oncology, Vol. 2, Iss. 3, 2009-10 ,pp. : 194-202

Karger

Access to resources Recommend Favorite

De novo CD5-Positive Diffuse Large B Cell Lymphoma Solely Presenting as Multiple Subcutaneous Nodules

Acta Haematologica, Vol. 107, Iss. 4, 2002-05 ,pp. : 230-233

Karger

Access to resources Recommend Favorite

Novel agents for diffuse large B-cell lymphoma

By Sinha Rajni DeJoubner Nutan Flowers Christopher

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 669-680

Informa Healthcare

Access to resources Recommend Favorite

Diffuse large B-cell lymphoma primary of lung

By Neri Natividad Jesús Nambo M Avilés Agustin

Hematology, Vol. 16, Iss. 2, 2011-03 ,pp. : 110-112

Maney Publishing

Access to resources Recommend Favorite